Search results
Better Buy: Bluebird Bio Vs. Novavax
Motley Fool via Yahoo Finance· 1 week agoWith that said, of these two companies, Bluebird Bio is the slightly better option. Though Novavax's revenue and cash position look stronger, it is...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
How can companies address consumers who are averse to products using a novel technology?
Phys.org· 7 days agoThe study, which appears in the Journal of Marketing, is titled "Adoption of New Technology Vaccines...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 2 days agoInvestors are disappointed because Novavax missed out on the biggest vaccine revenue opportunity in...
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape· 1 week agoA study of more than 9000 family physicians in Ontario also found that the physicians with the...
4 Years In, a Sobering Look at Long COVID Progress
Medscape· 1 week agoFour years ago in the spring of 2020, physicians and patients coined the term "long COVID" to describe a form of the viral infection from which recovery...
